{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:13:06Z","timestamp":1769047986277,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00423-021-02222-9","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T15:03:04Z","timestamp":1623164584000},"page":"2441-2448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Malignant prediction in paragangliomas: analysis for clinical risk factors"],"prefix":"10.1007","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-9558","authenticated-orcid":false,"given":"Miquel","family":"Torres-Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Febrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"2222_CR1","unstructured":"Thompson LD, Young WF, Kawashima A, Komminoth P (2004) Malignant adrenal phaeochromocytoma. In: DeLellis RA, Lloyd RV\u00a0(eds) World health organization classification of tumours pathology & genetics tumours of endocrine organs, 3rd edn. IARC, Lyon, pp 147\u2013150"},{"key":"2222_CR2","doi-asserted-by":"publisher","unstructured":"Gunawardane PTK, Grossman A (2017) Phaeochromocytoma and paraganglioma. Adv Exp Med Biol 956:239\u2013259. https:\/\/doi.org\/10.1007\/5584_2016_76","DOI":"10.1007\/5584_2016_76"},{"key":"2222_CR3","volume-title":"WHO classification of tumours of endocrine organs, vol. 10","author":"R Lloyd","year":"2017","unstructured":"Lloyd R, Osamura R, Kl\u00f6ppel G, Rosai J (2017) WHO classification of tumours of endocrine organs, vol. 10, 4th edn. IARC Press, Lyon","edition":"4"},{"key":"2222_CR4","volume-title":"Malignant adrenal phaeochromocytoma Pathology and genetics of tumours of endocrine organs","author":"L Thompson","year":"2004","unstructured":"Thompson L, Young W, Kawashima A, Komminoth P, Tischler A (2004) Malignant adrenal phaeochromocytoma Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon"},{"issue":"1","key":"2222_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","volume":"23","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Tischler AS, de Krijger RR (2012) Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol 23(1):4\u201314","journal-title":"Endocr Pathol"},{"issue":"9","key":"2222_CR6","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WF Jr, Iniguez-Ariza NM, Kittah NE, Gruber L, Bancos C et al (2017) Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab 102(9):3296\u20133305","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2222_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12020-011-9545-3","volume":"40","author":"TI Korevaar","year":"2011","unstructured":"Korevaar TI, Grossman AB (2011) Pheochromocytomas and paragangliomas: assessment of malignant potential. Endocrine 40(3):354\u2013365","journal-title":"Endocrine"},{"issue":"3","key":"2222_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T et al (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab 96(3):717\u2013725","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2222_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s002689900139","volume":"20","author":"DS O\u2019Riordain","year":"1996","unstructured":"O\u2019Riordain DS, Young WF Jr, Grant CS, Carney JA, Van Heerden JA (1996) Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20(7):916\u2013922","journal-title":"World J Surg"},{"key":"2222_CR10","doi-asserted-by":"publisher","unstructured":"van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F (2002) The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147(1):85\u201394. https:\/\/doi.org\/10.1530\/eje.0.1470085","DOI":"10.1530\/eje.0.1470085"},{"key":"2222_CR11","doi-asserted-by":"publisher","unstructured":"Kim KY, Kim JH, Hong AR, Seong MW, Lee KE, Kim SJ, Kim SW, Shin CS, Kim SY (2016) Disentangling of malignancy from benign pheochromocytomas\/paragangliomas. PLoS One 11(12):e0168413. https:\/\/doi.org\/10.1371\/journal.pone.0168413","DOI":"10.1371\/journal.pone.0168413"},{"issue":"1","key":"2222_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y (2005) Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16(1):23\u201332","journal-title":"Endocr Pathol"},{"issue":"6","key":"2222_CR13","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18(6):R253\u2013R276","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2222_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/jcm7090242","volume":"7","author":"N Kimura","year":"2018","unstructured":"Kimura N, Takekoshi K, Naruse M (2018) Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine. J Clin Med 7(9):242","journal-title":"J Clin Med"},{"issue":"5","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"P Plouin","year":"2016","unstructured":"Plouin P, Amar L, Dekkers O, Fassnacht M, Gimenez-Roqueplo A, Lenders J et al (2016) European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174(5):G1\u2013G10","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2222_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N et al (2014) Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21(3):405\u2013414","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1148\/rg.275065729","volume":"27","author":"CM Intenzo","year":"2007","unstructured":"Intenzo CM, Jabbour S, Lin HC, Miller JL, Kim SM, Capuzzi DM et al (2007) Scintigraphic imaging of body neuroendocrine tumors. Radiographics 27(5):1355\u201369","journal-title":"Radiographics"},{"issue":"12","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1002\/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7","volume":"88","author":"JC Jansen","year":"2000","unstructured":"Jansen JC, van den Berg R, Kuiper A, van der Mey AG, Zwinderman AH, Cornelisse CJ (2000) Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 88(12):2811\u20132816","journal-title":"Cancer"},{"key":"2222_CR19","unstructured":"Lack EE (1997) Tumors of the adrenal gland and extra-adrenal paraganglia. In: Rosai J (ed) Atlas of tumor pathology. Ser 3, fasc 19. Armed Forces Institute of Pathology,\u00a0Washington, DC,  p 303\u2013409"},{"issue":"2","key":"2222_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ctrv.2010.07.002","volume":"37","author":"KF Andersen","year":"2011","unstructured":"Andersen KF, Altaf R, Krarup-Hansen A, Kromann-Andersen B, Horn T, Christensen NJ et al (2011) Malignant pheochromocytomas and paragangliomas\u2013the importance of a multidisciplinary approach. Cancer Treat Rev 37(2):111\u2013119","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2222_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00268-007-9360-4","volume":"32","author":"JA Lee","year":"2008","unstructured":"Lee JA, Duh QY (2008) Sporadic paraganglioma. World J Surg 32(5):683\u2013687","journal-title":"World J Surg"},{"issue":"5","key":"2222_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.amjsurg.2010.04.012","volume":"201","author":"A Harari","year":"2011","unstructured":"Harari A, Inabnet WB III (2011) Malignant pheochromocytoma: a review. Am J Surg 201(5):700\u2013708","journal-title":"Am J Surg"},{"key":"2222_CR23","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1530\/EJE-16-0189","volume":"175","author":"L Amar","year":"2016","unstructured":"Amar L, Lussey-Lepoutre C, Lenders J, Djadi-Prat J, Plouin P-F, Steichen O (2016) Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. Eur J Endocrinol 175:R135\u2013R145","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2222_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.juro.2010.12.050","volume":"185","author":"F Feng","year":"2011","unstructured":"Feng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X et al (2011) Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J Urol 185(5):1583\u20131590","journal-title":"J Urol"},{"issue":"5","key":"2222_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1590\/2359-3997000000299","volume":"61","author":"K Gunawardane","year":"2017","unstructured":"Gunawardane K, Grossman A (2017) The clinical genetics of phaeochromocytoma and paraganglioma. Arch Endocrinol Metabol 61(5):490\u2013500","journal-title":"Arch Endocrinol Metabol"},{"issue":"3","key":"2222_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4158\/EP.15.3.194","volume":"15","author":"M Al-Harthy","year":"2009","unstructured":"Al-Harthy M, Al-Harthy S, Al-Otieschan A, Velagapudi S, Alzahrani AS (2009) Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas. Endocr Pract 15(3):194\u2013202","journal-title":"Endocr Pract"},{"issue":"12","key":"2222_CR27","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00268-010-0744-5","volume":"34","author":"A Agarwal","year":"2010","unstructured":"Agarwal A, Mehrotra PK, Jain M, Gupta SK, Mishra A, Chand G et al (2010) Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg 34(12):3022\u20133028","journal-title":"World J Surg"},{"issue":"5","key":"2222_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LD Thompson","year":"2002","unstructured":"Thompson LD (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26(5):551\u2013566","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2222_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00423-011-0850-3","volume":"397","author":"P de Wailly","year":"2012","unstructured":"de Wailly P, Oragano L, Rad\u00e9 F, Beaulieu A, Arnault V, Levillain P et al (2012) Malignant pheochromocytoma: new malignancy criteria. Langenbeck\u2019s archives of surgery 397(2):239\u2013246","journal-title":"Langenbeck\u2019s archives of surgery"},{"issue":"4","key":"2222_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","volume":"33","author":"D Wu","year":"2009","unstructured":"Wu D, Tischler AS, Lloyd RV, DeLellis RA, de Krijger R, van Nederveen F et al (2009) Observer variation in the application of the pheochromocytoma of the adrenal gland scaled score. Am J Surg Pathol 33(4):599\u2013608","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2222_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, P\u0119czkowska M, Bausch B, McWhinney SR, Muresan M et al (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943\u2013951","journal-title":"JAMA"},{"issue":"1","key":"2222_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12020-017-1310-9","volume":"59","author":"E Sbardella","year":"2018","unstructured":"Sbardella E, Cranston T, Isidori AM, Shine B, Pal A, Jafar-Mohammadi B et al (2018) Routine genetic screening with a multi-gene panel in patients with pheochromocytomas. Endocrine 59(1):175\u2013182","journal-title":"Endocrine"},{"issue":"5","key":"2222_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","volume":"20","author":"L Fishbein","year":"2013","unstructured":"Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL (2013) Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol 20(5):1444\u20131450","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2222_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ejhg.2013.128","volume":"22","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Favier J, Pertuit M, Delage-Corre M, Lopez S, Teissier M-P et al (2014) A MEN1 syndrome with a paraganglioma. Eur J Hum Genet 22(2):283\u2013285","journal-title":"Eur J Hum Genet"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-021-02222-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T18:06:57Z","timestamp":1636481217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-021-02222-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1007\/s00423-021-02222-9","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the study\u2019s reference hospital, and the participation of other hospitals was approved by the appropriate competent entities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participant included in the genetic analyses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}